Bentham Science Logo

Track Your Manuscript:

Letters in Drug Design & Discovery

Volume 18, 12 Issues, 2021
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


Letters in Drug Design & Discovery, Volume 2 - Number 1

Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy

, 2(1): 26 - 35

Stefano Margaritora, Alfredo Cesario, Venanzio Porziella, Pierluigi Granone, Alessia Catassi and Patrizia Russo

DOI: 10.2174/1570180053398361

Design of a Heteroaryl Modified, 1,5-Disubstituted Pyrazole Cyclooxygenase-2 (COX-2) Selective Inhibitor

, 2(1): 40 - 43

M. Ezawa, D. S. Garvey, D. R. Janero, S. P. Khanapure, L. G. Letts, A. Martino, R. R. Ranatunge, D. J. Schwalb and D. V. Young

DOI: 10.2174/1570180053398451


K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05


New Year Offer 2021

Related Journals

Related eBooks

eBooks Catalog